Layer A — cited: COA practices, testing, enforcement, provenanceLayer B — disclaimed: online sentiment, community reportsIndependence firewall: the Trust Index is computed from cited facts only — never sold, never sorts the directory.

V0 · V1 · V2 · V3 · V4

Overview

Independence-firewalled vendor profile · Trust Index computed from cited facts

AmbioPharm

ambiopharm.comUnder reviewResearch use only

US-facing research-peptide supplier, pharmaceutical (cGMP API); the ambiopharmpeptides.com storefront also advertises GMP/GLP and non-GMP/GLP 'research' grades-grade, founded 2005. Publishes certificates of analysis. Identity and claims are vendor-stated unless cited. Research use only.

Publishes COAsGMP claimDomestic shipping

—products listed

—Trustpilot

2005founded

Candidateconfidence

2026-06-27 as of

Vendor Trust Index

/100

Provisional — Insufficient Data

Not enough cited data to compute a Trust Index. Absence of evidence is not evidence of badness.

Coverage72%

ConfidenceModerate

Cited facts35

A transparency readout of 35 cited facts — never sold, never sorts the directory; not a safety verdict (RUO). How it’s computed →

Catalog breadth

—

No data available

External rating

—

No data available

COA policy

Cited

Yes

publishes COAs

Operating status

Cited

Under review

as of 2026-06-27

Trust Index breakdown

DerivedV3

The Trust Index weighs five evidence pillars — purity claims-vs-reality, testing transparency, enforcement conduct, operational accountability and reputation integrity — into a single 0–100 factor. Nothing here can be bought.

Provisional — Insufficient Data. This listing is under review; the Trust Index is withheld until verification completes. A precise number is withheld rather than guessed — absence of evidence is never shown as a low score.

Evidence at a glance

DerivedV3

Products listed: 4
Publishes COAs: Yes
Independent tests tracked: 0
Enforcement records: 0
Cited sources: 35

Methodology & independence

CitedV4

The Trust Index is computed only from cited facts — and can never be bought.
Sponsorship & affiliate are excluded by construction — they never move the score, sort, or inclusion.
Facts are dated and cited; absent data lowers confidence, never the score (absence isn’t evidence of bad).

No affiliate relationship with this vendor.

Legitimacy signals

DerivedV2

Official domain: ambiopharm.com
Payment: Not disclosed
Third-party testing: Not confirmed
Published COAs: Yes
HQ disclosed: US-SC
Sponsored placement: No

Vendor details

CitedV1

Founded (claimed): 2005
HQ: US-SC
Address: North Augusta, South Carolina, USA (Aiken County) — global HQ; second cGMP site in Shanghai, China
Contact: sales@ambiopharm.com
Ships from: US, CN
Ships to: US, international
Categories: Peptide APIs (cGMP) · Generic peptide APIs · Custom peptide synthesis (SPPS / LPPS / hybrid)
Grade claimed: pharmaceutical (cGMP API); the ambiopharmpeptides.com storefront also advertises GMP/GLP and non-GMP/GLP 'research' grades
Website: ambiopharm.com

WHOIS: Company founded 2005 (confirmed by the May 2026 CordenPharma acquisition press release and multiple outlets); some directory snippets list 2004 or 2006 — minor variance, treat 2005 as authoritative. South Carolina operations established 2007 in a ~10,000 sq ft North Augusta Industrial Park facility. WHOIS for ambiopharm.com and especially ambiopharmpeptides.com was not retrieved and should be checked at review to test the storefront-affiliation question. prnewswire.com

Find them

Verify you are on ambiopharm.com — 4 domain variants exist; this is the one on record as current.

V5 · V6 · V7 · V8 · V9

Products & price

Vendor-listed prices, dated & cited — no ranking, no commission

Product catalog & pricelist

CitedV5

4 representative listings captured on 2026-06-27. Prices are vendor-listed and dated; price-per-mg is a unit price, not a ranking. No commission is earned and no vendor is ranked. Research use only.

Compound	Price	Price / mg
RERetatrutideResearch peptides (GLP-1/GIP/glucagon triple agonist)	—	—
SESemaglutideResearch peptides (GLP-1 analog)	—	—
TITirzepatideResearch peptides (GLP-1/GIP dual agonist)	—	—
LILiraglutideResearch peptides (GLP-1 analog)	—	—

No prices captured (2026-06-27). The core ambiopharm.com business is a B2B peptide API CDMO that quotes custom-synthesis programs, not list prices. The ambiopharmpeptides.com storefront advertises 'competitive pricing', a stated 20% academic discount and the option to split orders into multiple shipments, but exposed no per-product pricing in search snippets and was not directly fetched; all storefront commercial terms are unverified.

Price-per-mg snapshot

DerivedV7

No data availableNo price series collected.

Deals & bulk pricing

CitedV8

20% academic discount; orders can be split into multiple shipments over time (ambiopharmpeptides.com) ambiopharmpeptides.com

Price snapshot

DerivedV6

No data availableRequires price data.

Shipping & fulfillment

CitedV9

Ships from: US, CN
Ships to: US, international
Domestic shipping: Yes
Ship speed: No data available
Payment: No data available

ambiopharmpeptides.com

Watch & alerts

V30

Status-change & enforcement alerts
Add to a comparison set

V10 · V11 · V12

Quality & COA verification

COA & testing practices

CitedV10

What this vendor proves about identity, purity & potency

Publishes COAs

policy on record

Third-party tested

not on record

Independent tests tracked

not on record

GMP / ISO claim

vendor-claimed

As a cGMP peptide API CDMO, AmbioPharm (ambiopharm.com) supplies full quality documentation / Certificates of Analysis to its B2B pharma and biotech clients per regulatory requirement; both its North Augusta, SC and Shanghai, China sites are described as regularly FDA-inspected. SEPARATELY, a consumer-facing storefront, ambiopharmpeptides.com, claims to send a Certificate of Analysis before shipping every order — this storefront claim is snippet-only and its affiliation with the real CDMO is unconfirmed (see knownDomains and review.issues).

Methods: cGMP in-house QC as a peptide API manufacturer (HPLC / MS implied by API CDMO status); AmbioPharm is the manufacturer, not an independent re-tester. No independent third-party purity assays (Janoshik / Finnrick / vialaudit) of AmbioPharm-branded retail product were found..

COA repository · published lab results

No data availablePer-lot COA records have not been collected.

Independent test results

V11

No data availableNo independent assays tracked for this vendor.

Authenticity & anti-spoofing

CitedV12

Official domain: ambiopharm.com

Only order from the official domain. Research-chem vendors are frequently impersonated by typosquats — verify the URL before purchase.

Known domain variants

ambiopharm.com — official · Corporate site of AmbioPharm, Inc., the B2B cGMP peptide API CDMO (the seed homepage). Not a direct-to-consumer storefront.
ambiopharmpeptides.com — variant — affiliation unconfirmed · Consumer/research-facing 'Premium Peptides for Sale' storefront using the AmbioPharm name and brand, selling research peptides (incl. retatrutide and other GLP-1 analogs) direct, with a claimed 'pharmaceutical warehouse in Clearwater/Aiken-area, South Carolina'. Whether this is an official AmbioPharm retail arm or a brand-collision/impersonator could NOT be confirmed. It lists the official-domain email sales@ambiopharm.com (a point toward affiliation) but a regulated GMP API CDMO mid-acquisition selling unapproved GLP-1 drugs direct-to-consumer would be a major compliance inconsistency. HUMAN REVIEW REQUIRED.
ambiopharm.com.cn — official (China) · Shanghai AmbioPharm site / brochure host (ambiopharm.com.cn) for the China cGMP facility.
ambiorx.com — related — unconfirmed · 'Ambio' (ambiorx.com) presents as a peptide drug-development company sharing branding/management-team naming with AmbioPharm; relationship (sister entity vs separate) not definitively established. Surfaced, not asserted.

V13 · V14 · V15 · V16 · V17

Reputation & sentiment

Online sentiment

Community signalUGC · disclaimedV13

Forum sentiment: unknown · unverified

A coarse community read, not a measured score. Platforms can be gamed — corroborate.

Reddit & community

UGC · disclaimedV14

No data availableCommunity mentions are not collected for this vendor.

Review sites

UGC · disclaimedV15

No data availableNo external ratings on file.

AmbioPharm is a B2B peptide API CDMO with essentially no consumer-review footprint (no Trustpilot/BBB/Reddit/peptide-aggregator profile found). The separate ambiopharmpeptides.com retail storefront also has no established independent review record located as of 2026-06-27. Reputation signal here is corporate/industry press, not consumer reviews.

User reviews

Not collectedUGC · disclaimedV16

No data availableNo first-party reviews have been collected for this vendor.

Press & media

CitedV17

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

CordenPharma / PR Newswire · 2026-05-27

prnewswire.com

Astorg-backed CordenPharma acquires AmbioPharm, strengthening its global peptide development and manufacturing platform

Astorg · 2026-05-27

astorg.com

CordenPharma inks AmbioPharm buyout to continue peptide production expansion

BioSpace · 2026-05-27

biospace.com

AmbioPharm Expanding Aiken County Operations with Nearly $119 Million Investment, 202 New Jobs

SCbio / SC Dept. of Commerce · 2026-06-17

scbio.org

AmbioPharm Expands North Augusta, South Carolina, Production Operations

Area Development · 2026-06-19

areadevelopment.com

AmbioPharm Appoints Industry Veteran Brian Gregg as CEO

Business Wire · 2023-10-02

businesswire.com

AmbioPharm Breaks Ground on $28M Expansion of Pharmaceutical Manufacturing Site in Shanghai

PharmiWeb · 2024-11-21

pharmiweb.com

V18 · V19 · V20 · V21

Trust, risk & enforcement

Enforcement & legal history

CitedV18

Warning letters, raids, shutdowns, BBB actions — cited or omitted

No enforcement actions on record. No FDA warning letters, raids, recalls, or import alerts naming this vendor as of 2026-06-27. Absence of record is not a guarantee.

We publish negative records only with a source, and offer vendors a right of reply.

Buyer safety checklist

DerivedV19

Publishes COAs
Third-party tested
Accepts non-crypto payment
Has reship / refund policy
Clean enforcement record
Currently operating

3 of 6 checks clear · derived from vendor-stated data.

Operating status & continuity

CitedV20

Status: Under review
Last confirmed: 2026-06-27
US-facing: Yes
Domain history: 4 variants on record
Known rebrands / aliases: None on record

Company founded 2005 (confirmed by the May 2026 CordenPharma acquisition press release and multiple outlets); some directory snippets list 2004 or 2006 — minor variance, treat 2005 as authoritative. South Carolina operations established 2007 in a ~10,000 sq ft North Augusta Industrial Park facility. WHOIS for ambiopharm.com and especially ambiopharmpeptides.com was not retrieved and should be checked at review to test the storefront-affiliation question.

If they disappear: prepaid / crypto orders carry no recourse if any research-chem vendor changes domains or shuts down with little notice.

Scam & non-delivery reports

Community-reportedUGC · disclaimedV21

No data availableCommunity scam/non-delivery reports are not collected for this vendor.

V22 · V23 · V24

Compare & discover

Compare vendors

V22

See AmbioPharm side-by-side with every vendor on the directory — COA practices, testing, shipping, enforcement history.

Similar vendors

V23

No data availableSimilar-vendor matching is not yet computed.

Best value for

V24

Cross-vendor price ranking is intentionally not computed

The Trust Index rates each vendor against a fixed evidence rubric — it never ranks vendors against each otheror sorts the directory. Naming a “best-value” vendor per compound would require exactly that cross-vendor sort, so we don’t. Compare the cited price-per-mg in the Products & price table yourself, or open a side-by-side comparison.

V25 · V26 · V27 · V28 · V29 · V31

Compliance, meta & tools

Jurisdiction & legality

CitedV25

Ships to: US, international
US-facing: Yes
Gating: Commercial links suppress where a compound is restricted in your region

Commercial CTAs are jurisdiction-gated; reference content stays visible everywhere (RUO).

Independence & disclosure

CitedV26

Affiliate: No
Sponsored placement: None
Effect on Trust Index: None — sponsorship & affiliate are excluded by construction

No affiliate or sponsorship relationship on record.

Data confidence & provenance

CitedV27

Reviewed by: PeptideCompass editorial
Sources: 35 cited
Captured: 2026-06-27
Provenance: web_research + adversarial_verification

View 35 sources

FAQ

CitedV31

Is AmbioPharm a research-peptide vendor?

AmbioPharm, Inc. (ambiopharm.com) is primarily a B2B contract development & manufacturing organization (CDMO) for peptide active pharmaceutical ingredients, founded in 2005, headquartered in North Augusta, South Carolina with a second cGMP site in Shanghai, China, and is being acquired by CordenPharma (announced May 2026). It supplies pharmaceutical and biotech companies, not consumers. A separate storefront, ambiopharmpeptides.com, sells research peptides direct under the AmbioPharm name, but its affiliation with the real CDMO is unconfirmed. Research use only.

ambiopharm.com

Is AmbioPharm FDA-inspected?

AmbioPharm states both its North Augusta, SC and Shanghai, China cGMP facilities are regularly audited and inspected by the FDA as a peptide API manufacturer. No FDA warning letter to AmbioPharm itself was located. Note this is FDA inspection of a contract API manufacturer, which is distinct from any consumer 'peptides for sale' storefront. Research use only.

ambiopharm.com

Who owns AmbioPharm?

AmbioPharm is privately held. The May 2026 CordenPharma acquisition press release names Carlyle Asia as a strategic shareholder; other directory sources (CB Insights, Craft) list MVM Partners as a private-equity owner, and MVM Partners published its own note on the deal — sources disagree, so ownership is reported as a conflict pending review. Founder and Chairman is Juncai Bai; Brian Gregg (ex-Bachem Americas COO) was appointed CEO in October 2023. Research use only.

prnewswire.com

Citable summary (GEO)

DerivedV29

AmbioPharm (ambiopharm.com) is a US-facing research-peptide vendor. Publishes certificates of analysis. No enforcement actions on record. PeptideCompass Trust Index: Provisional — Insufficient Data — This listing is under review; the Trust Index is withheld until verification completes.. Data is candidate and dated 2026-06-27. The Trust Index is an evidence-transparency readout of cited facts — not a safety verdict, never sold. Research use only.

JSON-LD: Organization · BreadcrumbList · FAQPage. Computed from cited facts, never sold.

Contribute, report & claim

V28

Reports are moderated · not verified by PeptideCompass